<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d303" origId="Cabergoline"><sentence id="DrugDDI.d303.s0" origId="s0" text="DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide."><entity charOffset="0-8" id="DrugDDI.d303.s0.e0" origId="s0.p0" text="DOSTINEX" type="drug"/><entity charOffset="78-92" id="DrugDDI.d303.s0.e1" origId="s0.p7" text="phenothiazines" type="drug"/><entity charOffset="94-108" id="DrugDDI.d303.s0.e2" origId="s0.p8" text="butyrophenones" type="drug"/><entity charOffset="128-142" id="DrugDDI.d303.s0.e3" origId="s0.p11" text="metoclopramide" type="drug"/><pair e1="DrugDDI.d303.s0.e0" e2="DrugDDI.d303.s0.e1" id="DrugDDI.d303.s0.p0" interaction="false"/><pair e1="DrugDDI.d303.s0.e0" e2="DrugDDI.d303.s0.e2" id="DrugDDI.d303.s0.p1" interaction="false"/><pair e1="DrugDDI.d303.s0.e0" e2="DrugDDI.d303.s0.e3" id="DrugDDI.d303.s0.p2" interaction="false"/><pair e1="DrugDDI.d303.s0.e1" e2="DrugDDI.d303.s0.e2" id="DrugDDI.d303.s0.p3" interaction="false"/><pair e1="DrugDDI.d303.s0.e1" e2="DrugDDI.d303.s0.e3" id="DrugDDI.d303.s0.p4" interaction="false"/><pair e1="DrugDDI.d303.s0.e2" e2="DrugDDI.d303.s0.e3" id="DrugDDI.d303.s0.p5" interaction="false"/><negationtags>DOSTINEX should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide&lt;/xcope&gt;.</negationtags></sentence></document>